Host cell mobilization for in situ tissue regeneration.

Although small, localized injuries can be healed through the body's normal reparative process, large traumatic injury overwhelms this system and may result in a deficit of functional recovery, despite the use of conventional reconstructive modalities. Cell-based approaches using tissue engineering and regenerative medicine techniques have offered new opportunities for treatment. Although the fundamental principles of cell-based therapies have been demonstrated clinically on multiple tissue systems, usually a donor tissue biopsy and ex vivo cell manipulation prior to implantation in vivo are necessary. The goal of the present study was to investigate whether host biologic resources and environmental conditions could be used for in situ tissue regeneration, which may eliminate the need for donor cell procurement and subsequent in vitro cell manipulation. To address this aim, we implanted a common biomaterial into mice and characterized the infiltrating cells to determine their regenerative potential. We showed that host cell infiltrates are not entirely comprised of inflammatory and fibroblast-like cells and the normal inflammatory process can be altered by incorporating anti-inflammatory agents that influence the formation of scar tissue. In addition, the infiltrating cells are capable of differentiating into multiple cell lineages, including osteogenic, myogenic, adipogenic, and endothelial lineages, if appropriate conditions are provided. These results suggest that it is possible to recruit a predominance of cells with multilineage potential into a biomaterial scaffold. Therefore, it may be possible to enrich the infiltrate with such cell types and control their fate, provided the proper substrate-mediated signaling can be imparted into the scaffold for in situ tissue regeneration.

[1]  D J Williams,et al.  Tissue engineering and regenerative medicine: manufacturing challenges. , 2005, IEE proceedings. Nanobiotechnology.

[2]  W. Cui,et al.  Stem cell differentiation and expansion for clinical applications of tissue engineering , 2007, Journal of cellular and molecular medicine.

[3]  S. Bruder,et al.  Osteogenic differentiation of purified, culture‐expanded human mesenchymal stem cells in vitro , 1997, Journal of cellular biochemistry.

[4]  J W Eaton,et al.  Molecular determinants of acute inflammatory responses to biomaterials. , 1996, The Journal of clinical investigation.

[5]  Daniel A. De Ugarte,et al.  Future of Fat as Raw Material for Tissue Regeneration , 2003, Annals of plastic surgery.

[6]  V. Serre-Beinier,et al.  Characterization of endothelial‐like cells derived from human mesenchymal stem cells , 2007, Journal of thrombosis and haemostasis : JTH.

[7]  J W Eaton,et al.  Molecular basis of biomaterial-mediated foreign body reactions. , 2001, Blood.

[8]  Narutoshi Hibino,et al.  Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. , 2005, The Journal of thoracic and cardiovascular surgery.

[9]  C. Attinger,et al.  Wound healing: an overview. , 2006, Plastic and reconstructive surgery.

[10]  A. Mescher,et al.  Regeneration or scarring: An immunologic perspective , 2003, Developmental dynamics : an official publication of the American Association of Anatomists.

[11]  Johnny Huard,et al.  Gene therapy and tissue engineering based on muscle-derived stem cells. , 2002, Current opinion in molecular therapeutics.

[12]  Anthony Atala,et al.  Urethral Stricture Repair With an Off-the-shelf Collagen Matrix , 2003 .

[13]  S. Soker,et al.  Propagation, expansion, and multilineage differentiation of human somatic stem cells from dermal progenitors. , 2005, Stem cells and development.

[14]  Anthony Atala,et al.  Recent developments in tissue engineering and regenerative medicine , 2006, Current opinion in pediatrics.

[15]  Chang-xing Huang,et al.  Hepatic stem cells: existence and origin. , 2003, World journal of gastroenterology.

[16]  Anderson,et al.  Host response to tissue engineered devices. , 1998, Advanced drug delivery reviews.

[17]  Michael Sittinger,et al.  Treatment of posttraumatic and focal osteoarthritic cartilage defects of the knee with autologous polymer-based three-dimensional chondrocyte grafts: 2-year clinical results , 2007, Arthritis research & therapy.

[18]  C. M. Agrawal,et al.  Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. , 1996, Biomaterials.

[19]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[20]  F. Gage,et al.  Mammalian neural stem cells. , 2000, Science.

[21]  P. Anthony Robbins' Pathologic Basis of Disease , 1990 .

[22]  F. Mouquet,et al.  CD31− but Not CD31+ Cardiac Side Population Cells Exhibit Functional Cardiomyogenic Differentiation , 2005, Circulation research.

[23]  James J. Yoo,et al.  Tissue-engineered autologous bladders for patients needing cystoplasty , 2006, The Lancet.

[24]  K. Leong,et al.  Biomaterials approach to expand and direct differentiation of stem cells. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[25]  Anthony Atala,et al.  Isolation of amniotic stem cell lines with potential for therapy , 2007, Nature Biotechnology.

[26]  J W Eaton,et al.  Inflammatory responses to biomaterials. , 1995, American journal of clinical pathology.

[27]  G. Holt,et al.  Soft-tissue response to synthetic biomaterials. , 1994, Otolaryngologic clinics of North America.